Press Releases Smith & Nephew Plc

Equities

SN.

GB0009223206

Market Closed - London S.E. Other stock markets 11:35:03 2024-04-26 am EDT			5-day change	1st Jan Change
981 ^GBX	+1.72%		+2.00%	-9.04%

Apr. 11	UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates	MT
Apr. 11	Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Smith+Nephew Announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention	Apr. 22	AQ
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention	Apr. 18	GL
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)	Apr. 04	GL
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds	Apr. 01	GL
Smith & Nephew : Directorate Change - Form 6-K	Mar. 28	PU
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner	Mar. 25	GL
Smith & Nephew : Notice of Annual General Meeting	Mar. 11	PU
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement	Feb. 28	GL
Smith & Nephew : +Nephew Fourth Quarter and Full Year 2023 Results	Feb. 26	PU
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting	Feb. 13	GL
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting	Feb. 12	GL
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting	Feb. 12	GL
New study confirms Smith+Nephew's REGENETEN Bioinductive Implant reduces full-thickness rotator cuff re-tear rates-1 by 68%	Jan. 12	AQ
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%	Jan. 11	GL
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	Dec. 12	AQ
Smith & Nephew : +Nephew announces change in Audit Committee Chair - Form 6-K	Dec. 06	PU
Smith & Nephew : +Nephew acquires novel cartilage regeneration technology for sports medicine knee repair - Form 6-K	Nov. 22	PU
Smith & Nephew : +Nephew acquires novel cartilage regeneration technology for sports medicine knee repair	Nov. 22	PU
Smith & Nephew : VESTING OF RESTRICTED STOCK UNIT AWARDS GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022 - Form 6-K	Nov. 13	PU
Smith & Nephew : NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM - Form 6-K	Nov. 09	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SMITH & NEPHEW : Strong ‘proof of execution’ to end FY23

February 29, 2024 at 07:52 am EST